Preview

Медицинский Совет

Расширенный поиск

Нужно ли назначать препараты кальция и витамина D: аргументы за и против

https://doi.org/10.21518/2079-701X-2013-4-2-70-75

Полный текст:

Аннотация

Сегодня известно, что кальций и витамин D являются одними из важнейших факторов здорового состояния организма в целом. Сбалансированное поступление кальция и витамина D является основой формирования и поддержания здоровой костной ткани, а недостаток этих веществ является фактором риска развития остеопороза и переломов.

Об авторе

Н. В. Торопцова
ФГБУ «НИИР им. В.А. Насоновой» РАМН, Москва
Россия


Список литературы

1. Bryere O., Malaise O., Neuprez A. et al. Calcium daily food intake in European postmenopausal women. Abstr. Sixth European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis // Osteoporosis Int. 2006. №17. S101.

2. Boonen S., Magowan S., Zhou X. et al. Prevalence of low calcium intake in postmenopausal osteoporotic women: the need for supplementation. Abstr. Sixth European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis // Osteoporosis Int. 2006. №17. S104.

3. Никитинская О.А., Торопцова Н.В. Социальная программа «Остеоскрининг Россия» в действии // Фарматека. 2012. №6. С. 90-93.

4. Seino Y., Ishizuka S., Shima M., Tanaka H. Vitamin D in bone formation // Osteoporos Int. 1993. №3. Р. 196-198.

5. van Driel M., Pols H.A.P., van Leeuwen J.P.T.M. Osteoblast differentiation and control by vitamin D and vitamin D metabolites // Curr. Pharm. Des. 2004. №10. Р. 2535- 2555.

6. Yamato H., Okazaki R., Ishii T. et al. Effect of 24R, 25-dihydroxyvitamin D3 on the formation and function of osteoclastic cells // Calcif. Tissue. Int. 1993. №52. Р. 255-260.

7. Visser M., Deeg D.J., Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam // J. Clin. Endocrinol. Metab. 2003. №88(12). Р. 5766-5772.

8. Dukas L., Schacht E., Bischoff H.A. Better functional mobility in community dwelling elderly is related to D hormone serum levels and to a daily calcium intake // J. Nutr. Health Aging. 2005. №9(5). Р. 347-351.

9. Bischoff-Ferrari H.A., Dawson-Hughes B., Staehelin H.B. et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials // BMJ. 2009. №339. doi:10.1136/bmj.b3692

10. Lips P. Vitamin D status and nutrition in Europe and Asia // J. Steroid. Biochem. Mol. Biol. 2007. №103(3-5). Р. 620-625.

11. Торопцова Н.В., Никитинская О.А., Беневоленская Л.И. Новый взгляд на профилактику остеопороза: фокус на Кальций-Д3 Никомед // Современная ревматология. 2007. №1. С. 64-68.

12. Rizzoli R., Boonen S., Brandi M.L. et al. Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 Recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) // Curr. Med. Res. Opin. 2013. №29(4). Р. 1-9.

13. Patient level pooled analysis of 68500 patients from seven major vitamin D fracture trials in US and Europe. The DIPART Group // BMJ. 2010. №340.

14. Chung M., Lee J., Terasawa T. et al. Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force // Ann. Intern. Med. 2011. №155. Р. 827-838.

15. Murad M.H., Elamin K.B., Abu Elnour N.O. et al. Clinical review: The effect of vitamin D on falls: a systematic review and meta-analysis // J. Clin. Endocrinol. Metab. 2011. №96. Р. 2997-3006.

16. Nagpal S., Na S., Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands // Endocr. Rev. 2005. №26. Р. 662-687.

17. Mathieu C., Adorini L. The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents // Trends Mol. Med. 2002. №8. Р. 174-179.

18. Mantell D.J., Owens P.E., Bundred N.J. et al. 1α,25-dihydroxyvitamin D3 inhibits angiogenesis in vitro and in vivo // Circ. Res. 2000. №87. Р. 214–220.

19. Gorham E.D., Garland C.F., Garland F.C. et al. Vitamin D and prevention of colorectal cancer // J. Steroid. Biochem. Mol. Biol. 2005. №97. Р. 179–194.

20. Giovannucci E., Liu Y., Rimm E.B. et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men // J. Natl. Cancer. Inst. 2006. №98. Р. 451–459.

21. Ahonen MH, Tenkanen L, Teppo L, et al. Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control 2000;11:847-52.

22. Feskanich D, Ma J, Fuchs CS, et al. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 2004;13:1502-8.

23. Garland CF, Garland FC, Gorham ED, et al. The role of vitamin D in cancer prevention. Am J Public Health 2006;96:252-61.

24. Lappe JM, Travers-Gustafson D, Davies KM, et al. Vitamin D and calcium supplementation reduces cancer risk: Results of a randomized trial. Am J Clin Nutr 2007; 85:1586-91.

25. Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H. Meta–analysis: longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment Pharmacol Ther. 2009;30(2):113–125.

26. Freedman DM, Looker AC, Chang SC, Graubard BI. Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst. 2007;99:1594-1602.

27. Peterlik M, Grant WB, Cross HS Calcium, vitamin D and cancer. Anticancer Res. 2009;29(9):3687-98.

28. Vitamin D and Calcium: A Systematic Review of Health Outcomes. AHRQ Publication No. 09-E015, August 2009. www.ahrq.gov

29. Shin MH, Holmes MD, Hankinson SE, Wu K, Colditz GA, Willett WC. Intake of dairy products, calcium, and vitamin d and risk of breast cancer. J Natl Cancer Inst. 2002;94:1301-0311.

30. Szodoray P., Nakken B., Gaal J., et al. The complex role of vitamin D in autoimmune diseases. Scand J Immun2008;68:261-269.

31. Cantorna MT. Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease. Prog Biophys Mol Biol 2006;92:60–4.

32. Lamb EJ, Wong T, Smith DJ, et al. Metabolic bone disease is present at diagnosis in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2002;16:1895–902.

33. Kamen DL, Cooper GS, Bouali H, et al. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 2006;5:114–7.

34. Haque U.J., Bartlett S.J. Relationships among vitamin D, disease activity, pain and disability in rheumatoid arthritis. Clin Exp Rheumatol 2010;28(5):745-7.

35. Zipitis CS, Akobeng AK. Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta–analysis. Arch Dis Child. 2008;93(6):512–517.

36. Pittas А.G., Lau J., Hu F., Dawson-Hughes B. The Role of Vitamin D and Calcium in type 2 diabetes. A systematic Review and Meta-Analysis* J Clin Endocrinol Metab. 2007; 92(6): 2017–2029.

37. Bolland M.J., Barber Р.А., Doughty R.N., et al. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ. 2008;336:262–266

38. Bolland MJ, Avenell A, Baron JA, et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ. 2010 Jul 29;341:c3691. doi: 10.1136/bmj.c3691.

39. Lewis JR, Calver J, Zhu K, et al. Calcium supplementation and the risks of atherosclerotic vascular disease in older women: results of a 5-year RCT and a 4.5-year follow-up. J Bone Miner Res. 2011 Jan;26(1):35-41.

40. Wang L, Manson JE, Song Y, Sesso HD. Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med. 2010 Mar 2;152(5):315-23.

41. Rejnmark L, Avenell A, Masud T. et al. Vitamin D with Calcium Reduces Mortality: Patient Level Pooled Analysis of 70,528 Patients from Eight Major Vitamin D Trials. J Clin Endocrinol Metab 2012;97:2670-2681

42. Michalsson K. Long term calcium intake and rates of all cause and cardiovascular mortality: community based prospective longitudinal cohort study. BMJ 2013;346:f228

43. Heaney RP.Calcium supplementation and incident kidney stone risk: a systematic review. J Am Coll Nutr. 2008;27(5):519-27.

44. Scientific opinion on the tolerable upper intake level of calcium. EFSA panel on dietetic products, nutrition and allergies (NDA). EFSA Journal 2012;10(7):2814

45. Никитинская О.А., Торопцова Н.В., Аникин С.Г. с соав. Профилактика первичного остеопороза у женщин комплексным препаратом Кальцемин Адванс (результаты открытого годового исследования). Научно- практическая ревматология, 2008 (3), стр 73-79.


Просмотров: 78


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)